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Examining the virulence of Candida
albicans transcription factor mutants
using Galleria mellonella and mouse
infection models
Sara Amorim-Vaz, Eric Delarze, Françoise Ischer, Dominique Sanglard* and
Alix T. Coste
Institute of Microbiology, University of Lausanne and University Hospital of Lausanne, Lausanne, Switzerland
The aim of the present study was to identify Candida albicans transcription factors
(TFs) involved in virulence. Although mice are considered the gold-standard model to
study fungal virulence, mini-host infection models have been increasingly used. Here,
barcoded TF mutants were first screened in mice by pools of strains and fungal burdens
(FBs) quantified in kidneys. Mutants of unannotated genes which generated a kidney
FB significantly different from that of wild-type were selected and individually examined
in Galleria mellonella. In addition, mutants that could not be detected in mice were also
tested in G. mellonella. Only 25% of these mutants displayed matching phenotypes
in both hosts, highlighting a significant discrepancy between the two models. To
address the basis of this difference (pool or host effects), a set of 19 mutants tested
in G. mellonella were also injected individually into mice. Matching FB phenotypes were
observed in 50% of the cases, highlighting the bias due to host effects. In contrast,
33.4% concordance was observed between pool and single strain infections in mice,
thereby highlighting the bias introduced by the “pool effect.” After filtering the results
obtained from the two infection models, mutants for MBF1 and ZCF6 were selected.
Independent marker-free mutants were subsequently tested in both hosts to validate
previous results. The MBF1 mutant showed impaired infection in both models, while
the ZCF6 mutant was only significant in mice infections. The two mutants showed no
obvious in vitro phenotypes compared with the wild-type, indicating that these genes
might be specifically involved in in vivo adaptation.
Keywords: Candida albicans, transcription factors, virulence, mice, Galleria mellonella
Introduction
Candida albicans is a common commensal microorganism that persists on the mucosal surfaces
of the human gastrointestinal tract and is also the most frequent human fungal pathogen (Odds,
1988). Superﬁcial infections of the skin and mucosa are the most common diseases associated
with this fungus. However, systemic infections (candidemia and invasive candidiasis) can occur in
patients with compromised immunity. Despite several treatment possibilities, the mortality rates
associated with these infections remain high, reaching 50% (Falagas et al., 2006; Leroy et al., 2009;
Pfaller and Diekema, 2010). Thus, a better understanding of the fungal biology, particularly the
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host-fungal crosstalk during systemic infection, is needed for the
development of new and more eﬀective therapies.
Candida albicans adapts to drastically diﬀerent environments,
and this characteristic is crucial for the ability of these pathogens
to cause invasive disease when transmitted frommucosal surfaces
to the blood and internal organs. Transcription factors (TFs) are
necessary to this process because these proteins mediate the rapid
integration of external signals and the metabolic reprogramming
to facilitate adaptation to the environmental conditions (Sellam
et al., 2014). Accordingly, TFs are interesting starting points for
the characterization of C. albicans biology, particularly virulence
traits and drug resistance mechanisms.
Previous studies have attempted to explore C. albicans biol-
ogy using diﬀerent approaches. One valid possibility for under-
standing the role of C. albicans TFs is to identify orthologs
in Saccharomyces cerevisiae. However, the evolution of the two
organisms has resulted in extensive transcriptional rewiring
(Rokas, 2006; Martchenko et al., 2007; Rokas and Hittinger, 2007;
Baker et al., 2013), suggesting that homologous TFs might have
diﬀerent functions in the two yeasts. Alternatively, a commonly
used approach is to generate mutant strains for genes encoding
TFs and screen these strains for in vitro and/or in vivo phe-
notypes. The latter approach is particularly interesting in the
context of virulence because these approaches generate infor-
mation on the behavior of pathogens within a living organism
(Noble et al., 2010; Vandeputte et al., 2011; Perez et al., 2013).
Another approach is to observe the phenotypes of strains carry-
ing hyperactive TF alleles produced through artiﬁcial activation
(Devaux et al., 2001; Schillig and Morschhauser, 2013) and artiﬁ-
cial TF overexpression (Devaux et al., 2001; Chauvel et al., 2012).
Despite these eﬀorts, many C. albicans regulatory circuits remain
poorly understood.
Although mouse models confer many advantages for inves-
tigating fungal pathogenesis, these gold standard models have
also been associated with some disadvantages, as mouse exper-
iments are costly, logistically challenging, time-consuming and
ethically delicate. To facilitate in vivo experimentation, a num-
ber of insect models have recently been developed for use
with fungal pathogens, such as the larvae of the insect species
Galleria mellonella (Cotter et al., 2000). These larvae have been
increasingly used to study fungal virulence and antifungal drug
activity (Brennan et al., 2002; Mylonakis et al., 2005; Coleman
et al., 2011; Thomaz et al., 2013; Favre-Godal et al., 2014). The
results obtained from this insect model were consistent with,
ﬁrst, those obtained from the mouse systemic model of infec-
tion but for a small number of mutants (Brennan et al., 2002;
reviewed in Coste andAmorim-Vaz, 2015) and, second, with data
on the pathogenicity of C. albicans strains in human patients
(Cotter et al., 2000). The larvae can be maintained between 12
and 37◦C, facilitating the study of temperature-related virulence
traits. The immune system of these insects can be compared
with the innate immunity of mammals, and the larvae immune
response to microorganisms can be assessed based on antimicro-
bial peptide (AMP) production or hemocyte counts (reviewed
in Coste and Amorim-Vaz, 2015). Considering these advan-
tages, G. mellonella is an interesting model for the large-scale
screening of fungal pathogens and antifungal drugs, thereby
narrowing the number of promising candidates for testing in
mice.
In recent years, we initiated the in vivo screening of
a C. albicans TF mutant collection using a mouse sys-
temic model of infection to identify factors crucial for C.
albicans virulence (Vandeputte et al., 2011). In a previ-
ous study, we focused on 77 mutants of the zinc cluster
(Zn2Cys6) family of TFs (Vandeputte et al., 2011), character-
ized by the conserved motif CX2CX6CX5−12CX2CX6−8C and
speciﬁc to the fungal kingdom (MacPherson et al., 2006),
revealing a single TF, Zcf13, which was important for C.
albicans infection in a mouse model of systemic infection
(Vandeputte et al., 2011).
In the present study, we screened 157mutants for other classes
of TFs using two diﬀerent animal models of infection and a
new statistical analysis of previously obtained results. First, out
of the total of 234 TF mutants injected into mice by pools and
assessed for fungal burden (FB) in mice kidneys, we identi-
ﬁed 47 mutants with increased or decreased tissue fungal loads,
out of which 39 mutants were not previously known to play
a role in virulence. These 39 mutants, along with 12 unde-
tected mutants in the mice kidneys, were next tested in single
strain infections. For ethical and ﬁnancial reasons, the individual
screening of these 51 mutants was performed using the alter-
native animal model G. mellonella. Thus, for the ﬁrst time, two
animal models, mouse and G. mellonella, were used in paral-
lel to compare the FBs of a large number of mutants with yet
unknown phenotypes. The results suggested that G. mellonella
represents a useful, rapid and valid model to detect mutants
with important defects in systemic host infection. Using this
approach, two TF mutants with altered host infection capacities
were identiﬁed.
Materials and Methods
Strains and Media
The C. albicans strains used in this study were obtained from a
collection of TF mutants available at the Fungal Genetic Stock
Center1 as previously described (Vandeputte et al., 2012). Each
TF mutant from this collection was transformed with a plas-
mid containing a barcode as previously described (Vandeputte
et al., 2011) and renamed BCYi for “BarCoded Yeast num-
ber i” (File S1). C. albicans strains were grown in complete
YEPD medium [1% Yeast Extract (Difco), 2% Bacto Peptone,
(Difco Laboratories, Basel, Switzerland) and 2% Dextrose (Fluka,
Buchs, Switzerland)], supplemented or not with 200 μg/ml
nourseothricin, or minimal medium YNB (Yeast Nitrogen Base)
(Difco), containing 2% glucose (Fluka). For growth on solid
media, 2% agar (Difco) was added. Escherichia coli DH5α
was used as a host for plasmid construction and propaga-
tion. DH5α was grown in LB (Luria-Bertani broth) or on
LB plates, supplemented with ampicillin (0.1 mg/ml) when
required.
1http://www.fgsc.net/
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Primers and Plasmids
The primers used in this study are listed in Supplementary Table
S1, and the plasmids are listed in Supplementary Table S2.
Yeast Transformation
Yeast transformation was performed as previously described
(Sanglard et al., 1996).
Construction of Deletion Mutants and
Revertant Strains with Nourseothricin
Resistance Cassettes
SC5314 was used as the parental strain to construct all marker-
free, full ORF deletion mutants. The 5′- and 3′-ﬂanking regions
(500 bp) of each targeted gene were PCR ampliﬁed using
the primers listed in Supplementary Table S1. The result-
ing fragments were introduced into pSFS2A (Reuss et al.,
2004; see Supplementary Table S2). This plasmid contains the
SAT1-ﬂipping cassette, including SAT1 (conferring resistance to
nourseothricin), which is controlled through the ACT1 promoter,
and recombinase (FLP), which is controlled through a maltose-
inducible promoter, and these genes were ﬂanked by recombinase
recognition target (FRT) sequences (Reuss et al., 2004). The
resulting deletion plasmids are listed in Supplementary Table S2.
The ﬁrst allele of targeted TFs was deleted using pSV3 digested
with KpnI and SacI (for ZCF6), pAC256 digested with KpnI
and SacI (for ZCF13), and pAC286 digested with ApaI and SacI
(forMBF1). Transformants from SC5314 were selected on YEPD
containing nourseothricin (200 μg/ml). After induction of the
recombinase in YEP medium containing 2% maltose for 4 h,
nourseothricin-susceptible clones that underwent SAT1 ﬂipping
were selected on YEPD agar plates containing only 15 μg/ml
nourseothricin after 24 h incubation. At this drug concentration,
susceptible C. albicans cells are still able to grow but much more
slowly than resistant cells. These procedures result in the deletion
of the targeted genes while maintaining intact 5′- and 3′- ﬂanking
regions. The second TF alleles of ZCF6 and MBF1 were subse-
quently deleted using the same deletion cassette. For ZCF13, the
second allele was deleted through transformation with pAC245
digested with KpnI and SacI, resulting in a second deletion cas-
sette internal to the ﬁrst cassette. Transformants were selected on
YEPD-nourseothricin (200 μg/ml), and examined using PCR to
conﬁrm the absence of wild-type alleles. Transformants without
wild-type alleles were grown in YEP medium containing maltose
(2%) for 4 h, and nourseothricin-susceptible clones were selected
on YEPD agar plates containing only 15 μg/ml nourseothricin
after 24 h incubation. To construct revertant strains, the wild-
type alleles and corresponding 5′-ﬂanking regions (500 bp)
were PCR ampliﬁed from SC5314 using the primers listed in
Supplementary Table S1. The resulting fragments were intro-
duced into plasmids containing deletion cassettes of the corre-
sponding TF genes, replacing the previously inserted 5′-ﬂanking
region, thus maintaining 3′-ﬂanking regions and reconstituting
wild-type alleles. Plasmids pSV4-1 and pSV4-2, containing the
two diﬀerent ZCF6 wild-type alleles, were digested with KpnI and
SacI. pAC291, containing theMBF1wild-type allele, was digested
with ApaI and SacI. Plasmid pAC253, containing the ZCF13
wild-type allele, was digested with KpnI and SacI. The result-
ing fragments were transformed into the corresponding mutant
strains, replacing one of the mutated alleles through homologous
recombination. The resulting strains are listed in Supplementary
Table S3.
Mice Experiments and Ethics Statement
All animal experiments were performed at the University
Hospital Center of Lausanne with approval through the
Institutional Animal Use Committee, Aﬀaires Vétérinaires du
Canton de Vaud, Switzerland (authorization n◦ 1734.2 and
1734.3), according to decree 18 of the federal law on animal pro-
tection. For all mice experiments, female BALB/c mice (6 weeks-
old; Charles River France) were housed in ventilated cages with
free access to food and water. The strains were grown in indi-
vidual tubes for 16 h under agitation at 30◦C in YNB or YEPD
medium. Each strain was subsequently diluted 100-fold in YEPD
medium and grown overnight under agitation at 30◦C.Overnight
cultures were washed twice with PBS and resuspended in 5 ml
PBS. The concentration of each culture was measured through
optical density, and each strain was diluted in PBS to the desired
concentration.
The mice were injected with pooled fungal strains as pre-
viously described (Vandeputte et al., 2011), and the statistical
analysis of the results was re-evaluated. Brieﬂy, the mice were
injected with pools of 10 C. albicans strains (wild-type, cmp1/
and 8 other mutants), and each strain carried a speciﬁc barcode.
DNA was extracted from the kidneys at 3 days post-infection
(dpi) and from an in vitro culture after 24 h. Each mutant was
quantiﬁed through qPCR targeting the barcode (see below). In
the present study, we considered the variability in the eﬃcacy of
qPCR reactions for the diﬀerent barcodes in the mutant strains
(Supplementary Table S4). Thus, Mann–Whitney tests were per-
formed to compare the FB scores of a givenmutant with the score
of a wild-type strain carrying the same barcode [see Quantitative
PCR (qPCR) and Normalization].
For colony-forming unit (CFU) experiments with single strain
infections, the mice were injected through the lateral tail vein
with 250 μl of a cell suspension containing 8 × 105 cells/ml.
At three dpi, the kidneys were recovered, and the CFU were
determined as previously described (Vandeputte et al., 2011).
The mutants were tested in groups of ﬁve mice, once or twice
(Experiment 1 and Experiment 2, see File S1). Statistical anal-
yses of the diﬀerences between CFU values were performed
using the Mann–Whitney test with a p ≤ 0.05 threshold.
Supplementary Table S5 shows the correlation between results
in the two subsets of mouse experiments. Additional statis-
tical analyses with a p ≤ 0.05 threshold or using the False
Discovery Rate (FDR = 0.05) according to Benjamini and
Hochberg (1995) were also performed (Supplementary Table S5,
File S1).
For survival experiments with single strain infections, groups
of 7–10 mice were used. The mice were injected through the lat-
eral tail vein with 250 μl of a cell suspension containing 2 × 106
cells/ml. The weight and health of the animals were monitored
daily. The post-infection day of natural death or euthanasia
of moribund animals was recorded for each mouse. Survival
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experiments were terminated at 15 days after infection. The sur-
vival experiments were repeated twice for zcf6/ and zcf13/
mutants and three times for the mbf1/ mutant. Statistical
analyses of the survival data were performed using the log-rank
(Mantel–Cox) test.
Preparation of C. albicans DNA from Mice
Kidneys
Candida albicans DNA was obtained from mouse kidneys as
previously described (Vandeputte et al., 2011).
Quantitative PCR (qPCR) and Normalization
Detection and quantiﬁcation of each strain obtained from mouse
kidneys infected with a pool of strains was performed through
qPCR based on the barcode corresponding to each strain, as pre-
viously described (Vandeputte et al., 2011). Brieﬂy, qPCR was
performed using DNA extracted from the kidneys of infected and
non-infected mice. The results obtained from the non-infected
control mice were used to deﬁne the noise level. Pools of strains
for which the CT for signature-tagged mutagenesis barcode 6
(STM6; wild-type strain) was higher than that of the non-infected
mice were rejected, as this result suggests that the C. albicans
DNA extraction failed. These samples were excluded from further
analysis. Ten standard curves were constructed, using 10-fold
serial dilutions (105–101 copies) of the ten CIp30-STM plasmids
and used to determine the copy number (Qx) of the barcode
of each strain, either extracted from mouse kidneys infected
with a pool of strains (QxINVIVO) or from the same pool of
strains grown in vitro (QxINVITRO). The “in vivo/in vitro” ratio
(dQx = QxINVIVO/QxINVITRO) was calculated for each STM bar-
coded strain, therefore normalizing the in vivo data to the in vitro
growth of each mutant strain. Moreover, to obtain the FB score
for each strain [S = log2 (dQx/dQSTM6)], each dQx ratio was
normalized to the dQSTM6 of the pool to normalize the results
of all pools. The STM6 barcode was present in isogenic wild-type
strains present in all the pools as a positive control.
RNA Extraction and Reverse Transcription
qPCR (RT-qPCR)
In order to verify the expression of ZCF6 and MBF1, RNA
was extracted from wild-type C. albicans cells (strain SC5314)
in exponential growth phase from in vitro cultures. It was also
extracted from infected mouse kidneys 48 h pi and from infected
G. mellonella 24 h pi. C. albicans in vitro cultured cells were
washed twice in PBS and then ﬂash-frozen with liquid nitro-
gen (N2). Mice kidneys were collected and directly placed in
RNAlater solution, then transferred to a mortar and ﬂash-frozen
with N2. Larvae were directly placed in a mortar and sacri-
ﬁced by ﬂash-freezing with N2. All samples were then processed
as follows: samples were ground until reduced to thin pow-
der. Approximately 100 mg of this powder was immediately
suspended in 600 μl of Trizol R© (Life Technologies), 300 μl of
phenol-chloroform-isoamyl alcohol 25-24-1 (Sigma), 300 μl of
RNA buﬀer (0.1 M Tris HCl pH 7.5, 0.1 M LiCl, 10 mM EDTA,
0.5% SDS) and the volume equivalent to 200 μl of acid-washed
0.5 mm-diameter glass beads in a screw-capped RNase-free 2 ml
tube. Cells were disrupted in a FastPrep 24 machine at 6.5 m/s for
15 s. After 5 min of centrifugation at 4◦C at 13000 g, supernatants
were transferred to a new RNase-free 1.5 ml microcentrifuge
tube and one volume of phenol-chloroform-isoamyl alcohol 25-
24-1 was added and vortexed for 10 s. The centrifugation was
repeated and the supernatant was transferred to a newRNase-free
1.5 ml microcentrifuge tube. RNA was precipitated with one vol-
ume of EtOH 100% and the solution was loaded into columns of
the DirectZolTM RNA MiniPrep kit (Zymo Research), thereafter
following the instructions of the manufacturer. A DNase treat-
ment was included in the kit and carried out in-column. Two
μl of RNasin R© Plus RNase Inhibitor (Promega) were added to
the ﬁnal RNA extracts and these were kept at −80◦C until fur-
ther use. For RT-qPCR, one microgram of RNA (determined by
NanoDrop 1000 Spectrophotometer, Thermo Fisher Scientiﬁc)
was reverse transcribed using random hexamers as a priming
method (Transcriptor High Fidelity cDNA Synthesis Kit, Roche).
Subsequent RT-qPCR reactions were performed with 0.2 μM
of each primer and 0.2 μM of probe for genes ACT1, MBF1,
and ZCF6 (see Supplementary Table S1), and iTAQ Supermix
with ROX (BioRad, Reinach, Switzerland) according to the man-
ufacturer’s instructions, using StepOnePlusTM Real Time PCR
System (Life Technologies). The expression level of ACT1 was
used for normalization, and fold change values were calculated
for MBF1 and ZCF6 in vivo versus in vitro. Technical duplicates
were included in each reaction, and all reactions were repeated
twice on biological duplicates.
G. mellonella Infection Model
Galleria mellonella larvae were purchased from Bait Express
GmbH (Basel, Switzerland). Upon arrival, the larvae were stored
with wood shavings at 12◦C in the dark and subsequently used
within a maximum of 2 weeks. Larvae with a weight ranging from
300 to 400 mg were used for the experiments.
Only single strain infections were performed in G. mellonella.
To determine the CFUs, groups of 5–10 larvae were used. Each
larva was injected through the last left proleg with 40 μl of a cell
suspension containing 2.5 × 106 cells/ml using a Myjector U-100
insulin syringe (Terumo Europe). A control group, injected with
40 μl of sterile PBS, and a group of non-injected larvae were
included. To verify that the injected volume did not negatively
aﬀect the larvae, we investigated the larvae survival following
ﬁve repetitive injections of 40 μl PBS over 2 days compared
with non-injected larvae. No negative eﬀect was observed (data
not shown). We also compared the survival of larvae injected
once with 40 μl of wild-type C. albicans using a Myjector U-100
insulin syringe versus larvae injected with 10 μl of the same
strain using a Hamilton syringe (same number of cells injected).
No diﬀerences were observed (data not shown). The larvae were
maintained at 30◦C in the dark, without food, and sacriﬁced
at 24 h post-infection. Subsequently, the fungal load of each
individual larva was determined. Brieﬂy, each larva was homoge-
nized in screw-cap tubes containing a metal bead [stainless steel,
7 mm, (VWR International)] with three rounds of shaking for
10 s at 6.5 m/s using a MP FastPrep R©-24 (MP Biomedicals). The
homogenate was immediately resuspended in 6 ml PBS, and two
10-fold serial dilutions in PBS were prepared. From each of the
three dilutions, 100 μl were plated onto YEPD-chloramphenicol
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(50 μg/ml) plates and incubated at 30◦C for 48 h. The CFU were
enumerated and expressed for each larva as a percentage of the
mean of the fungal load of the group infected with the wild-
type strain in the same experiment. Each mutant was tested (i)
twice using a minimum of ﬁve larvae (both experiments were
merged in Experiment 1), (ii) once using a minimum of 10 lar-
vae (Experiment 2), or (iii) both (see File S1). Statistical analyses
were performed using a ROUT analysis (Motulsky and Brown,
2006) to remove outliers, followed by the Mann–Whitney test
to assess CFU diﬀerences relative to the wild-type strain. For
survival experiments, groups of 12–15 larvae were used, and
each mutant was tested three times. The larvae were inoculated
with 40 μl of C. albicans cell suspension containing 1.25 × 107
cells/ml. A control group, injected with 40 μl of sterile PBS, and a
non-injected larvae group were included. The larvae were main-
tained at 30◦C in the dark, without food, and monitored twice
daily. The post-infection day of natural death was recorded for
each larva. The larvae were considered dead when no movement
and no response to a physical stimulus applied with tweezers
were observed. The survival experiments were terminated at
15–21 days after infection. Even if this time lapse is usually suf-
ﬁcient for the larvae to initiate metamorphosis, infection clearly
seemed to block it and therefore this process was not observed
during survival experiments. The statistical analyses of the sur-
vival data were performed using the log-rank (Mantel–Cox)
test.
In Vitro Phenotypic Tests
Fifty-two diﬀerent in vitro growth conditions, mimicking the
conditions relevant for systemic infection of the host, were
used to determine the phenotype of each mutant strain com-
pared with the wild-type parental strain. The yeast cultures were
grown overnight in liquid YEPD and diluted to a concentra-
tion of 2.5 × 107 cells/ml. Five 10-fold serial dilutions were
prepared at a ﬁnal concentration of 2.5 × 102 cells/ml. Four
microliters of each dilution were spotted onto YEPD-based plates
and incubated for 24–72 h at 35◦C unless otherwise speciﬁed.
First, heat and cold susceptibilities were tested through incu-
bation at 42 or 16◦C compared with the reference condition
at 35◦C. The strains were also grown in the presence of 5%
CO2. The sensibility to alkaline (pH 8.5 or pH 9.3, achieved
through the addition of HEPES 1 M pH 8.5 and NaOH 10 N,
respectively) or acidic pH (pH 3.35 or pH 2, achieved through
the addition of HEPES 1 M pH 1.9 and HCl 10 N, respec-
tively) was also veriﬁed. The use of alternative carbon sources
was assessed by growth on minimal medium (YNB) plates sup-
plemented with 2% glucose, 2% galactose, 2% sorbose, 2% raf-
ﬁnose, 2% maltose, 1% ethanol, 2% citrate, 0.1% acetic acid,
0.1% lactic acid, 0.1% maleic acid, 1 mM sorbic acid, 2% glyc-
erol, 0.1% sodium acetate, or 2% sorbitol. Growth in the pres-
ence of cell wall stress agents was determined after spotting the
strains onto YEPD plates supplemented with calcoﬂuor white
(100 μg/ml), Congo red (100 μg/ml) or 0.02% sodium dodecyl
sulfate (SDS). Susceptibility to oxidative stress was tested using
YEPD medium containing 5, 10, or 20 mM H2O2. Resistance
to salt stress was evaluated using YEPD medium supplemented
with 1 M NaCl, 1 mM CuSO4, 400 mM CaCl2, 400 mM
MgCl2, 200 mM LiCl, or 10 mM MnCl2. The growth of the
mutated strains was also evaluated in YNB minimal medium
without iron and calcium, or in the presence of the iron chela-
tor bathophenanthroline di-sulfonic acid (BPS; YEPD containing
100 μM BPS). Susceptibility to several drugs was also deter-
mined after supplementing YEPD medium with ﬂuconazole (10
or 40 μg/ml), ﬂuphenazine (50 μg/ml), 4-nitroquinoline 1-oxide
(4NQO; 10 μg/ml), caspofungin (0.1 μg/ml), amphotericin B
(1.5 μg/ml), phloxine B (5 mM), rapamycin (5 mM), caﬀeine
(2.5 mM), estrogen (20 μg/ml), benomyl (50 μg/ml), terbinaﬁne
(20 μg/ml), or ﬂucytosine (5-FC; 4 μg/ml; this last drug was
added to SD agar plates). Moreover, the ﬁlamentation phenotype
was determined after plating each mutant onto YEPD agar plates
supplemented with 10% fetal calf serum (FCS).
Results
In Vivo Screening of the TF Mutant
Collection
To identify the TFs important for C. albicans invasion and host
infection, we examined a collection of 234 mutants of putative
TF genes using an in vivo model. This collection includes 77 TF
mutants with a Zn2Cys6 cluster motif reported in a ﬁrst analy-
sis (Vandeputte et al., 2011) and another set (157 TF mutants)
analyzed in the present work. In both studies, the mutants were
tested in a mouse model of systemic infection through tail vein
injection, and FBs were determined in the kidneys at three dpi.
To reduce the number of animals needed, the mutants were
tested in pools of 10 strains, including eight mutant strains, one
wild-type strain and the calcineurin mutant strain (cmp1/) as
an avirulent control. Each pool was injected into at least three
mice (see File S1 and Vandeputte et al., 2011). We introduced a
barcode to distinguish between the diﬀerent strains. Thus, the
relative number of cells in the kidneys could be easily quanti-
ﬁed using qPCR based on the copy number of each barcode, as
previously described (Vandeputte et al., 2011). A colonization
score FB was determined for speciﬁc mutants relative to the wild-
type strain (calculation detailed in Materials and Methods) to
estimate the ﬁtness of the isolates. Next, to determine whether
mutants had FB scores signiﬁcantly diﬀerent from wild-type, a
threshold of signiﬁcance had to be determined. For this pur-
pose, we barcoded the wild-type strains using 10 diﬀerent tags,
obtaining 10 diﬀerent wild-type strains carrying a distinct bar-
code. Similar to the analysis of the TF mutants, a FB score was
attributed to each wild-type barcoded strain relative to the strain
carrying the STM6 barcode. In our ﬁrst study (Vandeputte et al.,
2011), we considered that strains with a score above or below
that of the wild-type (mean ± 2 SD) had a FB score signiﬁcantly
diﬀerent from that of the wild-type. However, when we deter-
mined in this study the eﬃcacy of the qPCR targeting the 10
diﬀerent barcodes, it ranged from 61.6 to 94.1% (Supplementary
Table S4), thus introducing a bias in the analysis. In the present
work, a bias correction was introduced in the analysis of all tested
mutants as well as for those examined in our previous study
(Vandeputte et al., 2011). We excluded the results obtained when
the qPCR eﬃcacy was below 80%, thereby excluding mutants
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bearing the tag STM224. Next, we used Mann–Whitney analy-
ses to compare the scores of each mutant strain with those of
the wild-type strain carrying the same barcode (File S1) to cir-
cumvent the qPCR bias. Mutants with less than three calculated
scores were considered non-detected and were not included in
the statistical analysis. Finally, with the obtained FB scores that
were signiﬁcant (47 mutants, p ≤ 0.05), individual mutants were
ranked as low- or high- FB mutants. The ﬁnal results are pre-
sented in Supplementary Figure S1 and Tables 1A,B. Twenty-six
mutants exhibited low FB scores (p≤ 0.05; Table 1A) and among
them six mutants (RIM101, NOT5, RFX1, SEF1, HAP43, and
SPT3) had been previously described as important for virulence
(Davis et al., 2000; Laprade et al., 2002; Cheng et al., 2003; Hao
et al., 2009; Hsu et al., 2011; Vandeputte et al., 2011). We also
identiﬁed 21 high FB mutants (p ≤ 0.05) and among them two
mutants (UPC2 and CTF1) were previously reported as critical
for virulence (Ramirez and Lorenz, 2009; Lohberger et al., 2014).
Ramirez and Lorenz (2009) and Lohberger et al. (2014) reported
that the CTF1 and UPC2 mutants, respectively, were less viru-
lent than the wild-type, and this result was not consistent with
the results obtained in the present study. Notably, the CTF1 and
UPC2mutants in Ramirez and Lorenz (2009) and Lohberger et al.
(2014) were null mutants constructed in diﬀerent genetic back-
grounds and tested in single strain infections. In addition, 19
mutants could not be detected from kidneys of animals infected
with pools (Table 1B). From these non-detected mutants, seven
were previously reported to display decreased virulence in mice
(Lo et al., 1997; Braun et al., 2000; Singh et al., 2004; Dagley et al.,
2011; Yan et al., 2014). The remaining 12 non-detected mutants,
not yet annotated, represent interesting candidates for further
study (Table 1B).
To estimate the validity of the approach used herein, we com-
pared the results in the present study with annotations of null
mutants examined using so-called “classic genetics” (i.e., indi-
vidual testing in mice) and available in the Candida Genome
Database2. For this analysis, we considered the non-detected
strains and the low FB phenotype strains in the same group,
reasoning that the lack of detection of the mutants reﬂected an
extremely low FB. We observed that 62.5% of the mutants exam-
ined here showed amatching phenotype with respect to virulence
when compared to previous annotations (File S1-Venn Diagram
and Supplementary Table S5). In this group, we identiﬁed genes
critical for pH (RIM101) or iron homeostasis (SEF1 and HAP43)
and yeast-hypha switching (EFG1, TUP1, NOT5, and SPT3).
The validation of our assays is therefore supported by these
results.
Recent population genetics analyses have shown that strain
communities, such as mutant pools, experience a phenomenon
called “clonal interference,” which can be considered as a “pool
eﬀect” (see Discussion; Vandeputte et al., 2011), which might
bias the phenotype of a given mutant. Therefore, we sought to
conﬁrm the low- and high FB mutant phenotypes obtained in
the pool infection by performing single strain infections. For
this purpose, mutants with annotations referring to altered vir-
ulence were excluded (8 out of 47 mutants), thus yielding 39
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interesting mutants (Table 1A). We also assessed the pheno-
types of 12 non-detected mutants with no previous annota-
tions relative to virulence in single strain infections (Table 1B).
Taken together, 51 mutant strains (39 with a signiﬁcant FB
score but not yet annotated and 12 not detected in pool infec-
tions of mice) were selected for testing through single strain
infections.
Screening Candidate TF Mutants in the
Alternative G. mellonella Model
A high number of animals are required to individually examine
51 mutants in mice, which is not ethically suitable. Therefore, we
used the larvae of the greater wax moth, G. mellonella, to perform
single strain infections. G. mellonella is a model organism used
in recent studies to examine fungal virulence and antifungal drug
eﬃcacy. This in vivomodel of systemic infection provides results
closely correlating with those obtained using the standard mouse
model (reviewed in Coste and Amorim-Vaz, 2015). Most stud-
ies perform survival tests using individual strains in this insect
model. In the present study, we assessed the larvae FB based on
CFU counting to compare them with the results obtained from
the initial screening using the mouse model. To our knowledge,
this comparison has not been previously attempted at such a
large scale. First, we performed a preliminary experiment using
a wild-type strain to determine the optimal inoculum for injec-
tion and the optimal lapse time before CFU counting. The results
are shown in Supplementary Figure S2. We determined that 24 h
post-infection was a better time-point than 48 h to obtain a clear
dose-response (from 103 to 106 cells per larva) in which most
of the larvae survived. We used 105 cells per larva as inoculum
to remain within the linear range of the dose-response curve.
Next, we screened the 51 selected mutant strains, and the results
are shown in Figure 1. We used the calcineurin null mutant
(cmp1/) as an avirulent control in G. mellonella. The CFU
counts determined from cmp1/ strain infected larvae revealed
signiﬁcantly lower FBs than those obtained with the wild-type
strain, thereby validating this approach. Using the mean FB of
the wild-type strain (included in each experiment and set at
100%) as a reference, low- and high- FB mutants were considered
below and above the 100% threshold, respectively, considering a
p ≤ 0.05 (Mann–Whitney test). Interestingly, in this assay, high
variability was observed with the wild-type strain. In the present
study, the diﬀerence in CFU counting in G. mellonella larvae was
as high as 100-fold for the same mutant (Figure 1). After orga-
nizing the results according to the phenotype observed in the
mouse model of pool infections, we observed that several low
FB mutants in mice switched phenotype in G. mellonella (change
from low- to high- FB phenotypes) or lost phenotype in this host
(no diﬀerence between wild-type and mutant strains). The same
pattern was observed for mutants with high FB phenotype in
mice. Thus, in contrast with previous reports, we observed sig-
niﬁcant discrepancies between the results obtained using these
two models of infection when analyzing FBs in target organs
in mice and G. mellonella, with only 21.5% of matching results
between the two sets of experiments (File S1-Venn Diagram and
Supplementary Table S5). This value could be increased to 30.7%
using another statistical approach, in which multiple t-tests were
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FIGURE 1 | Fungal burden (FB) of BCY mutants in G. mellonella single
strain infections. For each individual larva, the FB is expressed as a
percentage relative to the mean of the wild-type group in the same experiment.
This normalization enables comparisons between different experiments. All
Galleria mellonella experiments are pooled in this graph. The results are
expressed as the mean of the group and the minimum and maximum values.
The results are organized according to the phenotype observed in mice pool
infections. The green bar corresponds to the wild-type strain. The yellow bar
corresponds to the cmp1/ mutant (avirulent control). The red bars
correspond to low FB mutants significantly different from wild-type in G.
mellonella. The blue bars correspond to high FB mutants significantly different
from wild-type in G. mellonella. The black bars indicate mutants not significantly
different from the wild-type. The dotted line indicates the level of the mean of the
wild-type strain set at 100%. Each mutant was tested at least twice using a
minimum of five larvae each time or once using a minimum of 10 larvae.
Statistical analyses were performed using a ROUT analysis to remove outliers
(Motulsky and Brown, 2006), followed by a Mann–Whitney test to assess CFU
differences relative to the wild-type strain.
corrected using FDR (0.05; Supplementary Table S5). However,
increasing the stringency of the statistics eliminates several viru-
lence genes, such as SEF1 (File S1). To maintain as many viru-
lence gene candidates as possible, we selected in the present study
the less stringent Mann–Whitney and non-FDR-corrected anal-
ysis. One important consideration is that in addition to the two
diﬀerent model organisms, the mode of infection also changed
as the mutants were tested in pools in mice but individually in
G. mellonella. Hence, these two sets of experiments confounded
two variables, including the type of host and the type of inoculum
(single strain versus pool).
Comparison of Single Strain Infections of
G. mellonella and Mice Injected with TF
Mutant Strains
Among the 51 selectedmutants tested inG.mellonella,we used 18
mutants to perform single strain infections in the mouse model to
facilitate a direct comparison of the twomodel organisms without
the inﬂuence of the “pool eﬀect”. This approach may also facil-
itate the comparison of the two modes of infection (pooled or
single strain infections), irrespective of the host. For this com-
parison, we used mutants with (i) the same FB phenotypes in
the G. mellonella single strain infection and mouse pool infec-
tion (i.e., CTA7, ZCF6, OPI1, ORF19.1565, ORF19.6713, GRF10,
and SWI4), (ii) opposite FB phenotypes (ZCF14, ZCF31, ZFU2,
RLM1, ORF19.2399, and ORF19.3928) in the two animal models,
(iii) a wild-type phenotype in G. mellonella, but signiﬁcantly
altered in the mouse pooled infections (ZCF39, ORF19.1178,
MDM34, and ORF19.5617), and (iv) non-detected in mice, but
a pronounced low FB phenotype in G. mellonella (MBF1).
This 18 selected mutants were tested twice (Experiment 1 and
Experiment 2, see ﬁle S1) in single strain infection in at least ﬁve
mice each time. We also added to these results the data previ-
ously obtained with the ZCF13mutant in the mouse single strain
infection (Vandeputte et al., 2011) since this mutant has potential
interest.
The results obtained in mouse model of single strain infec-
tions using these 18 strains are presented in Figure 2A. The
results are expressed as a percentage of the mean FB for the wild-
type of each experiment. Comparison of these results with those
obtained in G. mellonella experiments, including FB values of the
previously tested zcf13 mutant strain (Vandeputte et al., 2011),
provide information on the degree of the host eﬀect. Tenmutants
(∼50%) showedmatching phenotypes in the twomodels: ﬁve low
FB mutant strains (rlm1-, zcf6-, zcf13-, mbf1-, and zfu2 mutant
strains), two high FBmutant strains (swi4- and orf19.2399mutant
strains) and three wild-type strains (orf19.1178-, orf19.6713-, and
mdm34 strains). The remaining nine mutants showed conﬂicting
phenotypes in the two model hosts. These results suggest that the
phenotypes observed for ∼50% of the strains were dependent on
the host (Supplementary Table S5 and File S1-Venn Diagram).
The correlation between the mean FBs for the 19 analyzed G.
mellonella and mouse mutants (as a percentage relative to the
wild-type) are shown in Figure 2B, including the ZCF13mutant
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FIGURE 2 | Comparison of the results obtained using 19 mutant strains
in two different in vivo models, including G. mellonella and mice.
(A) Fungal burden of BCY mutants in mice single strain infections. For each
individual mouse, the FB in the kidneys is expressed as a percentage relative
to the mean of the wild-type group in the same experiment (set at 100% and
indicated as a dotted line). All experiments are pooled in this graph. Only the
results from mutants tested at least twice are presented here. The results are
organized according to the phenotype observed in G. mellonella single strain
infections. The green bar corresponds to the wild-type strain. The red bars
correspond to statistically low FB mutants in mouse single strain infections.
The blue bars correspond to high FB mutants significantly different from the
wild-type in mouse single strain infections. The black bars indicate no
significant difference from the wild-type. Each mutant was tested twice using
five mice each time. The statistical analyses were performed using a ROUT
analysis to remove outliers, followed by a Mann–Whitney test to assess CFU
differences relative to the wild-type strain. The horizontal bars indicate the
mean and minimum–maximum of FB for each mutant strain. (B) Correlation
between results obtained with G. mellonella (24 h pi) and mice (three dpi). Red
and blue data points correspond to mutants with the strongest alterations in
host systemic infectivity (low- and high- FB mutants, respectively). The data for
the zcf13 mutant were obtained from Vandeputte et al. (2011). Spearman’s
rank correlation coefficient: r = 0.30, p = 0.2. Excluding colored data points,
r = −0.17, p = 0.56. The dotted lines indicate the level of the mean of the
wild-type strain set at 100% in each model.
examined in mice in a previous study (Vandeputte et al., 2011).
The apparent correlation primarily reﬂected the edges of the
plot, in which the fungal load of the infected group containing
three low- mutants (ZFU2, ZCF13, and MBF1) and one high FB
mutant (SWI4) is highlighted among the middle aggregate data.
Considering these observations, G. mellonella is an interesting
in vivo model for the detection of mutants in which infectivity
is strongly aﬀected. Indeed, these four mutants displayed an FB
at least ﬁve times higher or lower than the FB of the wild-type
strain (Figure 2B).
The comparison of the results obtained in single strain with
pool infections in mice, including FB values of the previously
tested zcf13 mutant strain (Vandeputte et al., 2011), was used to
estimate the degree of the “pool eﬀect”. For themutants examined
in the present study, we observed matching phenotypes for only
33.4% of the strains with p < 0.05 and even to 50% when apply-
ing FDR (0.05;Table 1, Figure 2, Supplementary Table S5 and File
S1-Venn Diagram). These results indicate that around 50% of the
phenotypes observed in the mice pool infection experiments were
inﬂuenced by the pool eﬀect.
We reasoned that the most interesting mutants were those for
which infectivity was independent of the host or the pool eﬀect.
Consequently, we further investigatedmutant strains with low FB
phenotypes in the three tested infection models, namely the zcf6-,
zcf13-, andmbf1mutant strains.
Infection Assays with Independent Mutants
Notably, the selected mutants were constructed using two dif-
ferent strategies: UAU transposition (Davis et al., 2002) in
BCY130 (mutant for ZCF6) and BCY152 (mutant for ZCF13),
and 100-mer extension from pFA plasmids (Gola et al., 2003)
in BCY431 (mutant for MBF1). Therefore, these mutants con-
tain partial gene deletions and/or exhibit the ectopic expression
of auxotrophic markers. Importantly, the ectopic expression of
URA3 might inﬂuence the diﬀerences observed in the virulence
phenotype of C. albicans strains (Brand et al., 2004). To exclude
the possibility that the phenotypes observed in the present study
reﬂected artifacts in the C. albicans genome as a consequence of
these strategies, we examined a set of independent mutants of the
three candidate genes described above (ZCF6, ZCF13, andMBF1)
using the SAT1 ﬂipper cassette (Reuss et al., 2004) and SC5314 as
the parental strain. We also constructed revertant strains from
each mutant through the re-insertion of the wild-type alleles at
one deleted locus. None of these strains displayed growth defects
in vitro (Supplementary Figure S3).
The independent mutants for ZCF6, ZCF13, and MBF1 were
subsequently tested using a mouse model of systemic infection.
The FB in the kidneys was measured at 3 dpi (Figure 3A), and
survival curves were obtained for each mutant (Figure 3B). In
terms of systemic infection in the mouse (kidney FBs), mutants
for ZCF6 and MBF1 conﬁrmed the previously observed low
FB phenotype (mbf1/: p = 0.0002, zcf6/: p = 0.033).
Revertant strains, in which the wild-type allele was reintro-
duced, were also tested, revealing the same level of kidney FBs as
observed in the parental wild-type strain. The full ORF, marker-
free deletion mutant for ZCF13 showed a phenotype similar to
that of the wild-type, therefore the low FB phenotype in BCY152,
obtained through UAU transposition, was not observed with the
independent deletionmutant. In parallel, the threemutant strains
were examined in survival experiments. Only the MBF1 mutant
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FIGURE 3 | Testing an independent set of mutants in mice. (A) Fungal
burden of full ORF, marker-free C. albicans deletion mutants in mice single strain
infections. For each individual mouse, the FB in the kidneys is expressed as a
percentage relative to the mean of the wild-type group in the same experiment.
All experiments are pooled in this graph. The mean value of each group is
indicated with a black bar. The dotted line indicates the level of the mean of the
wild-type strain set at 100%. Each mutant was tested twice using five mice
each time (except for ZCF6 revertant 2 and MBF1 revertant). Statistical analyses
were performed using a Mann–Whitney test to assess CFU differences relative
to the wild-type strain. The stars indicate the level of statistical significance:
∗p < 0.05, ∗∗p < 0.01. (B) Survival curves in mice. The mice were injected with
5 × 105 cells of the corresponding strain and monitored daily. These survival
curves represent at least two independent experiments. Groups of 10 mice
were used each time. ∗∗∗∗p < 0.0001, log-rank test.
FIGURE 4 | Testing an independent set of mutants in G. mellonella.
(A) Fungal burden of full ORF, marker-free deletion mutants in G. mellonella
single strain infections. For each individual larva, the FB is expressed as a
percentage relative to the mean of the wild-type group in the same
experiment. All experiments are pooled in this graph. The mean of each
group is indicated with a black bar. The dotted line indicates the level of the
mean of the wild-type strain set at 100%. Each mutant was tested three
times using at least six larvae each time. Statistical analyses were performed
using a ROUT analysis to remove outliers (Motulsky and Brown, 2006),
followed by a Mann–Whitney test to assess CFU differences relative to the
wild-type strain. The star indicates the level of statistical significance:
∗p < 0.05. (B) Survival curves in G. mellonella. Larvae were injected with
5 × 105 cells of the corresponding strain and monitored twice daily. These
survival curves represent three independent experiments. Groups of at least
10 larvae were used each time. The log-rank test was performed, and no
significant differences were observed.
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showed attenuated virulence, with a median survival time of
9 days compared with 5 days for the wild-type and 4 days for
the revertant strain (p < 0.0001 in Log-rank test; Figure 3B).
TheMBF1mutant also displayed a signiﬁcant low FB phenotype
in G. mellonella (p < 0.05, Figure 4A). In contrast, no signif-
icant diﬀerences in larvae fungal loads were observed for the
ZCF6 mutant compared with wild-type (p = 0.12; Figure 4A).
Nevertheless, this mutant showed a clear tendency for lower
infection of the larvae than the wild-type, and this tendency was
reproducible across two diﬀerent experiments (mean Experiment
1 = 70.2%, mean Experiment 2 = 56.9% of the wild-type mean).
Interestingly, the variability observed inG. mellonellawas consis-
tently higher than that observed in the mouse model (Figures 3A
and 4A), thus masking statistically signiﬁcant results (considering
p-values ≤ 0.05 as threshold). These two mutants were further
evaluated in survival experiments in G. mellonella (Figure 4B),
and the results showed that none of the mutants exhibited a
survival phenotype diﬀerent from the wild-type.
In Vitro Phenotypic Characterization
To identify the biological processes involving the mutated genes,
we examined mutants that maintained a coherent phenotype
throughout the course of the study (MBF1 and ZCF6) and the
corresponding revertant strains under 52 diﬀerent in vitro condi-
tions. This allowed assessing the susceptibility of the TF mutants
to a variety of stresses (see Materials and Methods). Except for
mbf1/, which showed slightly increased resistance to ﬂucona-
zole, no phenotype could be observed for the two mutants under
any of the conditions examined (Supplementary Figure S3). This
suggests that these genes are speciﬁcally required for in vivo
conditions.
Expression of MBF1 and ZCF6 In Vitro and
In Vivo
Since no in vitro phenotypes were observed with the two tested
mutants, it is possible that MBF1 and ZCF6 are not expressed
in vitro. Thus their deletion would not yield any phenotype.
We therefore veriﬁed their expression both in vitro and in vivo.
However, expression of both genes could be measured in vitro
and in vivo from mouse kidneys (48 h post-infection) or G.
mellonella larvae (24 h post-infection; Supplementary Table S6).
These results demonstrate that the absence of in vitro phenotypes
for the mbf1/ and zcf6/ mutants is not due to lack of gene
expression, but rather reﬂects the use of phenotypic tests that did
not match the characteristics of these mutants.
Discussion
In the present study, we identiﬁed two new genes, MBF1 and
ZCF6, necessary for the systemic propagation of C. albicans in the
mammalian mouse model, but only one of these genes (MBF1)
was defective in the insectG.mellonella. Simultaneously, we com-
pared these two animal models of infection at a large scale. We
consider G. mellonella as an interesting model for preliminary
large-scale screenings to identify mutants with severe virulence
defects in vivo.
Screening of a C. albicans TF Mutant
Collection
We examined here a collection of C. albicans putative TFmutants
in an intravenous systemic mouse infection model using pools of
10 strains at a time (eight mutants and two controls). This strat-
egy spares animals and resources for identifying new potentially
interesting mutants. We observed that the phenotypes obtained
in the mouse pool infection experiments were 62.5% similar
to the phenotypes previously reported in studies using classic
genetics experiments, i.e., experiments in which the strains were
individually tested (see Supplementary Table S5). The diﬀerences
for the remaining 37.5% of the mutants can be attributed to dif-
ferent reasons. First, the number of animals used in our screening
experiments was low (3–6 animals/pool). Second, the annotations
in CGD were obtained with mutants constructed using diﬀerent
methods and diﬀerent genetic backgrounds. Third, these diﬀer-
ences can be due to competition between strains and/or to the
phenomenon of clonal interference. Experiments performed on
populations of bacteria or yeasts have demonstrated that the suc-
cess of a given mutant strain reﬂects not only the eﬀect of its
mutation itself but also the eﬀect of the genetic background of
the remaining population in the pool (Lang et al., 2013; Hammer
et al., 2014; Wolter and Hoﬀman, 2014). Despite these draw-
backs, we conclude here that pool infection experiments are still
trustworthy to narrow down the numbers of candidate mutants.
Nevertheless, one of the problems when quantifying the
relative distribution of barcoded mutants in pools by PCR
approaches is that the PCR reactions are not equally eﬃcient for
each barcode. In the present work, we corrected for this bias.
When re-evaluating data obtained in our previous study with
this correction (Vandeputte et al., 2011), we observed some dis-
crepancies in the ranking of high and low FB mutants. As an
example, we considered all zinc cluster TF mutants tested in
single strain infections and reported here or in separate stud-
ies (Chiranand et al., 2008; Ramirez and Lorenz, 2009; Chen
et al., 2011; Vandeputte et al., 2011; Lohberger et al., 2014). We
identiﬁed 19 zinc cluster mutants with annotations regarding
virulence. Among them, 61% were assigned the same FB pheno-
type in the present study. In contrast, only 32% were detected
in our previous analysis using a non-corrected approach for
qPCR eﬃciency (Vandeputte et al., 2011). These results clearly
emphasized the need to carefully analyze population distribu-
tion data obtained by PCR approaches. The use of univer-
sal primers for tag ampliﬁcation coupled with deep sequenc-
ing technologies may be better suited for future population
quantiﬁcations.
G. mellonella as an Infection Model to Study
C. albicans Virulence Factors
The G. mellonella model has been used by other groups, who
reported excellent correlations between the results obtained with
the insect model and those obtained with mice in survival exper-
iments (Cotter et al., 2000; Brennan et al., 2002). These previous
studies used mutants for genes with well-known and strong vir-
ulence defects, including EFG1, CPH1, CEK1, CDC35 (Brennan
et al., 2002) and CMP1 (Bader et al., 2006). In the present study,
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we did not estimate survival rates, but rather measured the
capacity of the mutants for systemic proliferation in the host.
In our hands, however, matching results between mouse and
G. mellonella single strain infections were observed in 50% of
the cases (Figure 2). The correlation between these two groups
of results primarily reﬂected the extreme phenotypes of the
strains that were strongly diﬀerent from the wild-type in mice
(ﬁvefold less or more kidney fungal loads than wild-type), also
observed as low- or high FB mutants in G. mellonella, respec-
tively. Thus, we concluded that this insect model is useful for
identifying mutants which exhibit major infection defects in
mice, potentially explaining why previous studies performed in
G. mellonella, using C. albicans mutants with strong virulence
defects in mice showed good virulence correlations between the
two models. However, mutants with moderate (but statistically
signiﬁcant) alterations in the FB phenotype in mice can be pre-
dicted to exhibit large discrepancies between the two diﬀerent
hosts.
The diﬃculty to reach statistical signiﬁcance using the insect
model might be explained by the increased variability of the
results. Comparing the 25–75 percentiles of the results observed
in Figures 1 and 2 for the wild-type, the variability observed using
the insect model was around 1,5-fold higher than in mice (G.
mellonella model: 33.1–154.1%; mouse model: 50–143.4%). This
variability also leads to a lower reproducibility of the experiments
than in mice. Comparison of the two rounds of experiments in
G. mellonella (Experiment 1 and Experiment 2) showed only
45.2% matching phenotypes, in contrast to the 61.1% match-
ing phenotypes obtained between the two rounds of experi-
ments in mice (Supplementary Table S5). G. mellonella larvae
were obtained from a commercial supplier not aimed for use
in research, likely contributing to this variability. Larvae were
not inbred (in contrast to mice) and the sanitary conditions,
temperature, and nutrition conditions of the insect storage and
transport are unknown. Another recent study in Cryptococcus
neoformans reports similar variability problems using this model.
The authors clearly showed thatG.mellonellawere obtained from
diﬀerent suppliers, and even diﬀerent batches from the same
supplier generated diﬀerent results (Eisenman et al., 2014). To
overcome this problem, G. mellonella cultures should be main-
tained in a standardized manner to facilitate the comparison of
results between diﬀerent laboratories. However, standardized cul-
ture maintenance would be a heavy burden for investigators in
terms of time consumed and logistical arrangements.
Assessing the Virulence of an Independent
Set of Mutants
Subsequent to screening in two hosts, we selected for further
analyses mutants for ZCF6, ZCF13, and MBF1. The C. albi-
cans mutants in the collection examined in the present study
were obtained using diﬀerent strategies: UAU-Tn7 transposi-
tion (Davis et al., 2002), 100-mer extension from pFA plasmids
(Gola et al., 2003), and 100-mer extension from UAU transpo-
son (Davis et al., 2002) or URA3 blaster (Fonzi and Irwin, 1993).
Notably, the ectopic expression ofURA3was later shown to cause
altered virulence in C. albicans (Brand et al., 2004). In addition,
the use of the UAU cassette to generate homozygous deletion
mutants can result in chromosome aneuploidy in C. albicans
(Legrand et al., 2008). Moreover, gene disruption through trans-
posons can result in the expression of truncated gene products
with unknown eﬀects on the cell (Lo et al., 2003). Thus, after
selecting the three most interesting C. albicansmutant strains, we
constructed independent, full ORF marker-free deletion mutants
for the same genes using the SAT1 ﬂipper cassette. However,
the ZCF13 marker-free full ORF deletion strain did not repro-
duce the low FB phenotype obtained with the BCY152 strain
(ZCF13 obtained by UAU-Tn7 transposition). Interestingly, the
revertant of BCY152, in which one copy of the wild-type gene
was re-introduced, restored the wild-type FB phenotype inmouse
kidneys (Vandeputte et al., 2011). Thus, it is clear that the reduced
capacity of BCY152 for host systemic infection is caused by an
insertional mutation in ZCF13 (Vandeputte et al., 2011). Given
that the complete deletion of this gene does not lead to the same
phenotype, we hypothesized that the mutation (and not a dele-
tion) in this gene is responsible for the observed phenotype.
Particularly, the insertion of a Tn7 transposon could be respon-
sible for the premature polyadenylation of the ORF, leading to
the translation of a truncated protein in BCY152. In a previous
study, Lo et al. (2003) designed a TAGKO (transposon arrayed
gene knockout) mutant in ﬁlamentous fungi and demonstrated
that the Tn7 insertion lead to the premature polyadenylation
of TAGKO transcripts, thereby leading to the translation of
truncated proteins in fungal mutants (Lo et al., 2003). We are
currently investigating this phenomenon in BCY152.
Two New Genes Involved in C. albicans
Virulence
Two new genes,MBF1 and ZCF6, were relevant for host systemic
infection. Interestingly, and even if both genes were shown to be
expressed in vitro, no in vitro phenotype was observed for either
of the two mutants, except for a slight increase in the resistance
of thembf1/ mutant to ﬂuconazole. These results suggest that
MBF1 and ZCF6 rather control host-speciﬁc features and should
be further investigated.
Little is known about ZCF6, except that this gene encodes a
putative TF with a zinc cluster DNA-binding domain. Although
the absence of this gene does not aﬀect the survival rates of
infected animals, the proliferation of these fungal mutants is
clearly and consistently impaired in vivo in both mammalian and
insect models. Future experiments will help clarify the function of
this gene, which might be speciﬁc for the in vivo host conditions,
and determine ZCF6-regulated genes during systemic infections.
MBF1 is an uncharacterized ORF with predicted sequence-
speciﬁc DNA binding activity, reﬂecting the presence of
a Cro/C1-type helix-turn-helix domain (IPR001387; Candida
Genome Database, Gene Ontology Annotations for MBF1).
A transcriptional coactivator has also been predicted based on
gene orthology with S. cerevisiae (Candida Genome Database,
Gene Ontology Annotations for MBF1). Concerning the func-
tion of MBF1 in baker’s yeast, this gene has been annotated in
the Saccharomyces Genome Database as a transcriptional coacti-
vator linking the DNA-binding region of the Gcn4p and TATA-
binding protein Spt15p (Takemaru et al., 1998), as a suppressor of
frameshift mutations (Culbertson et al., 1982). The abundance of
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S. cerevisiae Mbf1 protein increases in response to DNA replica-
tion stress (Tkach et al., 2012; Saccharomyces Genome Database,
Summary of MBF1/YOR298C-A).
Conclusion
With the growing pressure for reducing the use of mammalian
models, we conclude here that G. mellonella can be a valid
model to substitute mouse pool infection experiments, since
both approaches are reliable (50% phenotypic convergence as
compared to the gold-standard mouse single strain infection).
Thus, the two large scale screenings (G. mellonella single strain
and mouse pool infections) are interesting approaches to predict
mutants with a pronounced phenotype in the single strain infec-
tion mouse model. Accordingly, we were able in the present study
to identify mutants with a known role in virulence and also a new
factor, MBF1, which is annotated as a putative transcriptional
coactivator. MBF1 may therefore interact with several TFs, and
therefore be implicated in the regulation of a number of diﬀerent
pathways. We are currently exploring the function ofMBF1 using
in vivo transcriptional approaches to identify potential binding
partners.
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